Fimea supervises and develops the pharmaceutical sector and promotes the sensible use of pharmaceuticals in order to enhance the health of the population.
Sustainable well-being through safe medicines and medicinal products combined with effective service.
- We have an active role in national and international networks.
- We produce knowledge to support decision-making.
- We discover new insights and innovative
- and sustainable practices.
- We anticipate and develop.
Reliable and service-oriented
- We serve our customers openly and ethically.
- We keep our promises.
- We pool our expertise to serve common objectives.
- We value and support each other.
- We recognise our services and strengthen our processes.
- We upgrade our service channels.
- We strengthen the culture of service-oriented expertise and interaction with stakeholders.
Streamlined and enabling operating culture
- We optimise our way of working to meet the needs of the future.
- We define the principles of leadership.
- We define objectives for the development of our personnel.
National and international effectiveness
- We define objectives, policies and priorities for exerting influence nationally and internationally.
- We are the primary source of medicinal information for the Finns.
Internal drivers of change
- Information sharing
- Open collaboration with stakeholders
- Convergence of marketing authorisation and HTA operations
- Time- and location-independent work
- Concentration on core competencies
External drivers of change
- Regressing Europe, growing East Asia
- Unpredictability and proneness to crises
- Globalisation, centralisation, polarisation
- Crime and risks within the pharmaceutical sector
- Empowerment of citizens
- Flood of information
Drivers of change within the state
- The Health Care Reform
- Blurring of organisational boundaries
- Openness, transparency, ethical operations, responsibility
- Shared support services
- Ministry of Finance, the state parent company
- Independence from time and location
Technological drivers of change
- 24/7 online world
- Expensive advanced therapies
- Preventive and curative pharmacotherapies
- ATMP products, implants, diagnostics
- Automated distribution of medicines
- Technology and cyber security audits